These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 16930924

  • 21. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW, Kucia ML, Salata RA.
    Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
    [Abstract] [Full Text] [Related]

  • 22. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
    Swoboda S, Fritz S, Martignoni ME, Feldhues RA, Hoppe-Tichy T, Buchler MW, Geiss HK.
    J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
    [Abstract] [Full Text] [Related]

  • 23. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
    Zeana C, Kubin CJ, Della-Latta P, Hammer SM.
    Clin Infect Dis; 2001 Aug 15; 33(4):477-82. PubMed ID: 11462183
    [Abstract] [Full Text] [Related]

  • 24. [Linezolid-resistant Enterococcus faecium: the first G2576T mutation in Turkey].
    Afşar I, Barış I, Sener AG, Köksal V, Demirci M.
    Mikrobiyol Bul; 2012 Jul 15; 46(3):516-8. PubMed ID: 22951666
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
    Tsai TN, Wu CP, Peng MY, Giian CF, Lee SY, Lu JJ.
    Int J Clin Pract; 2006 Jun 15; 60(6):740-1. PubMed ID: 16805761
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hospital-acquired vancomycin-resistant enterococci: now appearing in Kuala Lumpur Hospital.
    Zubaidah AW, Ariza A, Azmi S.
    Med J Malaysia; 2006 Oct 15; 61(4):487-9. PubMed ID: 17243529
    [Abstract] [Full Text] [Related]

  • 30. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.
    Gómez-Gil R, Romero-Gómez MP, García-Arias A, Ubeda MG, Busselo MS, Cisterna R, Gutiérrez-Altés A, Mingorance J.
    Diagn Microbiol Infect Dis; 2009 Oct 15; 65(2):175-9. PubMed ID: 19717261
    [Abstract] [Full Text] [Related]

  • 31. Linezolid-resistant Enterococcus faecium and Enterococcus faecalis isolated from a septic patient: report of first isolates in Germany.
    Halle E, Padberg J, Rosseau S, Klare I, Werner G, Witte W.
    Infection; 2004 Jun 15; 32(3):182-3. PubMed ID: 15188081
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I, Beuran M, Dimov R, Razbadauskas A, Bochan M, Fichev G, Dukart G, Babinchak T, Cooper CA, Ellis-Grosse EJ, Dartois N, Gandjini H, 307 Study Group.
    J Antimicrob Chemother; 2008 Sep 15; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM, Sun J, Iwen PC, Rupp ME.
    Clin Infect Dis; 2008 Jan 01; 46(1):30-6. PubMed ID: 18171210
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vancomycin-resistant Enterococcus bacteremia: an evaluation of treatment with linezolid or daptomycin.
    Twilla JD, Finch CK, Usery JB, Gelfand MS, Hudson JQ, Broyles JE.
    J Hosp Med; 2012 Mar 01; 7(3):243-8. PubMed ID: 22076962
    [Abstract] [Full Text] [Related]

  • 37. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
    Deville JG, Adler S, Azimi PH, Jantausch BA, Morfin MR, Beltran S, Edge-Padbury B, Naberhuis-Stehouwer S, Bruss JB.
    Pediatr Infect Dis J; 2003 Sep 01; 22(9 Suppl):S158-63. PubMed ID: 14520141
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
    Forrest GN, Arnold RS, Gammie JS, Gilliam BL.
    J Infect; 2011 Dec 01; 63(6):420-8. PubMed ID: 21920382
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.